-transparent.png){kind=logo}
Between January 1970 and December 1989, 153 consecutive patients with stage I or II Hodgkin's disease were treated at the Medical College of Wisconsin Affiliated Hospitals. Eighty-eight patients were clinically staged and 65 patients underwent staging laparotomy. Ninety-nine patients were treated using continuous split course irradiation (CSCI) technique. Overall survival (OS) at 5, 10, and 15 years was 89%, 79%, and 68%, respectively. Disease-free survival (DFS) at 5, 10, and 15 years was 75%, 72%, and 68%, respectively. No significant differences were found in OS or DFS when comparing pathologically and clinically staged patients or when comparing patients treated using CSCI with those treated with the standard technique. Patients treated using CSCI tended to complete therapy in a shorter time, without increased morbidity.
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
April 1983,
Australian and New Zealand journal of medicine,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
January 1975,
The American journal of roentgenology, radium therapy, and nuclear medicine,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
August 1990,
British journal of cancer,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
June 1997,
Nederlands tijdschrift voor geneeskunde,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
July 1999,
American journal of hematology,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
March 1982,
Blood,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
March 1994,
Wisconsin medical journal,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
October 1991,
Cancer,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
June 1989,
Hematology/oncology clinics of North America,
D B Rock, and
C J Schultz, and
K J Murray, and
J F Wilson, and
J D Cox
June 1982,
Southern medical journal,
